AJJ — Asian American Medical Share Price
Momentum
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -85.78% | ||
Return on Equity | -67.34% | ||
Operating Margin | -480.59% |
Financial Summary
Year End 31st Aug | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | SG$m | 15.17 | 17.48 | 7.67 | 4.82 | 1.16 | n/a | n/a | -41.59% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Health Trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Asian American Medical Group Limited is a Singapore-based company engaged in the provision of medical services for liver diseases and transplantation, radiation oncology and healthcare project management and consultancy services. The Company's segments include liver, Multi-Specialty, Healthcare Management and Consultancy, and Healthcare Real Estate. The liver segment operates is engaged in the business of treatment of all liver, pancreas and bile duct diseases in adults and children. The Multi-Specialty segment is a medical specialist in Singapore and abroad, mainly in the United States and Great Britain. The Multi-Specialty, Healthcare Management and Consultancy segment is focused on sourcing and identifying potential healthcare-related projects. THe Healthcare Real Estate segment is managed under the Company’s subsidiary Asian American Healthcare Ventures Pte Ltd (AAHV).
Directors
- Angela Choong CFO
- Dario Nazzari SEC
- Heng Boo Fong LED (71)
- Kong Ang NED
- Wee Kian Leong NED
- Evgeny Tugolukov NED (45)
- Fey Yu Pang NID
- Last Annual
- August 31st, 2021
- Last Interim
- August 31st, 2021
- Incorporated
- February 11th, 2000
- Public Since
- March 19th, 2007
- No. of Shareholders
- 248
- No. of Employees
- 15
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS
- Shares in Issue
- 347,752,754

- Address
- 6A Napier Road, 258500
- Web
- https://www.aamg.co/
- Phone
- +65 64762088
- Auditors
- BDO Audit (SA) Pty Ltd
Upcoming Events for AJJ
Similar to AJJ
Althea group
Australian Stock Exchange - SEATS
Apiam Animal Health
Australian Stock Exchange - SEATS
Artrya
Australian Stock Exchange - SEATS
Australian Clinical Labs
Australian Stock Exchange - SEATS
Cann
Australian Stock Exchange - SEATS
FAQ
As of Today at 07:01 UTC, shares in Asian American Medical are trading at AU$0.04. This share price information is delayed by 15 minutes.
Shares in Asian American Medical last closed at AU$0.04 and the price had moved by +35.71% over the past 365 days. In terms of relative price strength the Asian American Medical share price has outperformed the ASX All Ordinaries Index by +33.6% over the past year.
There is no consensus recommendation for this security.
Asian American Medical does not currently pay a dividend.
Asian American Medical does not currently pay a dividend.
Asian American Medical does not currently pay a dividend.
To buy shares in Asian American Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.04, shares in Asian American Medical had a market capitalisation of .
Here are the trading details for Asian American Medical:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: AJJ
Based on an overall assessment of its quality, value and momentum Asian American Medical is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Asian American Medical. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +4.53%.
As of the last closing price of AU$0.04, shares in Asian American Medical were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Asian American Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.04.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Asian American Medical's management team is headed by:
- Angela Choong - CFO
- Dario Nazzari - SEC
- Heng Boo Fong - LED
- Kong Ang - NED
- Wee Kian Leong - NED
- Evgeny Tugolukov - NED
- Fey Yu Pang - NID